Literature DB >> 17923555

Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks.

Michele Rinaldi1, Roberto Dell'Omo, Mario R Romano, Flavia Chiosi, Ugo Cipollone, Ciro Costagliola.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17923555     DOI: 10.1001/archopht.125.10.1422

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  11 in total

1.  A case of intravitreal bevacizumab injection for the treatment of choroidal neovascularization in angioid streaks.

Authors:  Ji Woong Lee; Jae Pil Shin; Si Yeol Kim
Journal:  Korean J Ophthalmol       Date:  2011-05-24

2.  Acute stroke after intravitreal bevacizumab to treat choroidal neovascularization due to angioid streaks in pseudoxanthoma elasticum : a severe systemic adverse event after an off-label procedure.

Authors:  Gianluca Besozzi; Andrea Ferrara; Enrico Epifani; Daniela Intini; Margherita Apruzzese; Antonio Provenzano; Michele Vetrugno
Journal:  Int Ophthalmol       Date:  2012-10-14       Impact factor: 2.031

3.  Verteporfin photodynamic therapy combined with intravitreal triamcinolone for choroidal neovascularization due to angioid streaks.

Authors:  Alfredo Pece; Gaetano Russo; Federico Ricci; Vincenzo Isola; Ugo Introini; Giuseppe Querques
Journal:  Clin Ophthalmol       Date:  2010-06-24

4.  Changes in neovascular choroidal morphology after intravitreal bevacizumab injection: prospective trial on 156 eyes throughout 12-month follow-up.

Authors:  Ciro Costagliola; Francesco Semeraro; Ugo Cipollone; Michele Rinaldi; Michele della Corte; Mario R Romano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-04-29       Impact factor: 3.117

5.  Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis.

Authors:  Thi Ha Chau Tran; Christine Fardeau; Céline Terrada; Ghislaine Ducos De Lahitte; Bahram Bodaghi; Phuc Lehoang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-06       Impact factor: 3.117

6.  Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin) for treatment of angoid streaks in pseudoxanthoma elasticum.

Authors:  Martin Ganssauge; Helmut Wilhelm; Karl-Ulrich Bartz-Schmidt; Sabine Aisenbrey
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12       Impact factor: 3.117

7.  Ranibizumab for choroidal neovascularization secondary to pseudoxanthoma elasticum: 4-year results from the PIXEL study in France.

Authors:  Gérard Mimoun; Jean-Marc Ebran; Typhaine Grenet; Alain Donati; Salomon-Yves Cohen; Anne Ponthieux
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-05-10       Impact factor: 3.117

8.  Intravitreal Bevacizumab for Choroidal Neovascularization Associated with Angioid Streaks: Long-term Results.

Authors:  T Lekha; Hari Narayan Prasad; Renuka Nikit Sarwate; Manasi Patel; S Karthikeyan
Journal:  Middle East Afr J Ophthalmol       Date:  2017 Jul-Sep

9.  Choroidal neovascularization after blunt ocular trauma in angioid streaks.

Authors:  Masaomi Kubota; Takaaki Hayashi; Kota Arai; Hiroshi Tsuneoka
Journal:  Clin Ophthalmol       Date:  2013-07-03

10.  Batch-related sterile endophthalmitis following intravitreal injection of bevacizumab.

Authors:  Morteza Entezari; Alireza Ramezani; Hamid Ahmadieh; Hassan Ghasemi
Journal:  Indian J Ophthalmol       Date:  2014-04       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.